• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

MKC8866 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755005

MKC8866 is a selective IRE1 RNase inhibitor (IC50: 0.29uM in human vitro). MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibit prostate cancer (PCa) tumor growth. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
MKC8866, Inhibitor
Full Product Name
MKC8866
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
361.35
Solubility
DMSO: 16.67mg/mL (46.13mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C18H19NO7
SMILES
O=CC1=C(O2)C(C(C)=C(CC(N3CCOCC3)=O)C2=O)=CC(OC)=C1O
CAS Number
1338934-59-0
Target & IC50
IRE1 RNase: ic50 0.29uM
In Vitro
MKC8866 (oral ; 300mg/kg; for 28 days) decreases tumor regrowth post-NSC 125973 withdrawal[1].

Product Categories/Family for MKC8866, inhibitor

Structure of MKC8866, inhibitor

MKC8866 Inhibitor – Cat# MBS5755005

Product References and Citations for MKC8866, inhibitor

Sheng X, et al. IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat Commun. 2019 Jan 24;10(1):323.
Sheng X, et al. IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat Commun. 2019 Jan 24;10(1):323.
Logue SE, et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun. 2018 Aug 15;9(1):3267.
Logue SE, et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun. 2018 Aug 15;9(1):3267.

Other Notes

Small volumes of MKC8866, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for MKC8866 purchase

MBS5755005 is an inhibitor targeting MKC8866.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000